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Tumour thickness in oral cancer
using an intra-oral ultrasound probe
Abstract Objectives To investigate
tumour-thickness measurement with
an intra-operative ultrasound (US)
probe. Methods A retrospective data
analysis was undertaken for a total of
65 patients with a T1-2 oral cavity
cancer, who were seen at a tertiary
referral centre between 2004 and
2010. The correspondence between
tumour thickness measured by ultra-
sonography and histopathology was
assessed by Pearson’s correlation
coefﬁcient, and also between tumour
thickness and the development of
neck metastasis. Results In 11 cases,
intra-oral measurement was not opti-
mal due to limited mouth opening
(n=2) or impossibility to depict
the lesion (n=9). Tumour thickness
measured by US correlated well with
histopathology (n=23, R=0.93).
Tumour thickness of ≤7mm carries a
risk of lymph node metastasis of
12%, whereas in tumours exceeding
7mm this risk is 57% (p=0.001).
Twenty-ﬁve percent developed neck
metastasis and 19% had local recur-
rence. Conclusion Tumour thickness
is an important predictive marker for
lymph node metastases. As such, it
can help in decision-making with
regard to management of the primary
tumour and neck. Based upon our
ﬁndings, a wait-and-see policy is only
warranted for superﬁcial lesions with
tumour thickness of less than 7mm,
but only if regular follow-up using
US-guided aspiration of the neck is
ensured.
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Introduction
Predicting the risk of lymph node metastases in clinically
N0 patients with oral cancer is very important in treatment
planning for the neck. Tumour thickness has been shown
to be one of the most important features in predicting
lymph node metastases in oral cancer. Since 1986 several
studies have focused on tumour thickness [1–3]. In 2005,
Pentenero et al. [4] showed in a large review cut-off points
as prognostic factors ranging from 2 mm to 10 mm.
Table 1 shows cut-off values for all studies used in this
article and studies performed after the review of Pentenero
et al. [4]. Tumour thickness is not the only important
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The Netherlandspredictive factor; other important characteristics of the
tumour are: epidemiologic parameters such as age, sex,
race, alcohol, and/or tobacco intake, clinical parameters
(TNM stage, site) and histopathological parameters such
as the tumour border, being either inﬁltrative or more
pushing, perineural invasion and vascular invasion [4–6].
Recently, it has also been shown that gene expression of
the primary tumour correlates with the risk of cervical
metastases [7].
Separate from predicting the development of lymph
node metastases, the measurement of tumour thickness
may have implications for the treatment of the primary
tumour as well. Limited oral cancer in general is treated
surgically, using postoperative radiotherapy or chemo-
radiation in the case of unfavourable histopathological
features. In superﬁcial oral cancer, apart from local
excision, CO2 laser resections and photodynamic therapy
(PDT) have also been shown to yield excellent results [8].
However, the results of these alternative treatments are
very much dependent on the amount of tumour inﬁltration
(i.e. tumour thickness). Although depth of inﬁltration is
predictive for the chance of local recurrence as well [6], it
is not routinely used as an indication for postoperative
radiotherapy in most clinics. A recent study showed that
tumour thickness is also predictive for the risk of
contralateral cervical metastasis in tongue carcinoma [9].
To measure tumour thickness, different techniques are
available. Several studies have compared intra-oral ultra-
sound (US) with magnetic resonance imaging (MRI) or
computed tomography (CT) [10, 11]. In 1989, Iro and
Nitsche [12] showed that using a miniaturised transducer
enables the depiction of tumours of the anterior tongue and
the ﬂoor of the mouth without artefacts. They found this
method to be superior to conventional US for this region.
Since June 2007 we have been using a new intra-
operative transducer (Philips IU-22 L 15-7; 7–15 MHz).
In this study, we present our results with respect to the
feasibility of US measurement of intra-oral tumour thick-
ness, correlation with the presence of lymph node
metastases as well as correlation with MRI, with histo-
pathology as the “gold standard”.
Patients and methods
Ethical considerations
This was a retrospective study with anonymous evaluation of
data; therefore, written informed consent was not required.
Selection criteria
All patients with stage T1–T2 oral cancer planned for
transoral excision or photodynamic therapy (PDT) in our
department were included (n=65). All patients were seen
between 2004 and 2010.
Participants
Ages ranged from 42 to 89 years (mean 65 years) and the
sex ratio was 34 men to 31 women. The cancers were
localised in the tongue (n=38), the ﬂoor of the mouth (n=
22) and elsewhere in the mouth (n=5).
Clinical T-stages of the 65 patients were as follows: T1
(n=50), T2 (n=15); N-stages were: N0 (n=59), N1 (n=4)
and N2 (n=2).
Intra-oral US was used in all 65 patients, and MRI was
performed in 36 cases. MRI was only performed as part of
the preoperative treatment planning, in patients possibly
applicable for transoral excision. In 13 cases the lesion
was not found on MRI, because of superﬁcial growth.
These lesions were interpreted as minimal lesions of less
than 1-mm thick.
Table 1 Reviewed articles: from 1986 to 2009, displayed with number of patients, TNM stage, studied site, and cut-off values found by
ultrasound for N0 versus pathological N+ (FOM ﬂoor of mouth, N+ tumour thickness signiﬁcant for nodal involvement)
Reviewed articles Year Number patients TNM Site N+ Survival
Spiro et al. [1] 1986 92 Any TN Oral cavity 2 mm 2 mm
Mohit et al. [14] 1986 84 T1-2N0 FOM 1.5 mm –
Rasgon et al. [3] 1988 22 Any TN Oral cavity 5 mm –
Woolgar et al. [15] 1995 50 T2 Tongue 8 mm 8 mm
Martinez et al. [16] 1995 126 Any TN Oral cavity 7 mm –
Fukano et al. [13] 1996 34 Any TN Tongue 5 mm –
Shintani et al. [10] 1997 53 Any TN Oral cavity 8 mm –
Byers et al. [17] 1998 91 Any TN Tongue 4 mm –
Scheer et al. [18] 2005 64 Any TN Oral cavity 13 mm 14 mm
Veness et al. [19] 2005 99 Any TN Tongue 5 mm 5 mm
Jing et al. [20] 2006 45 Any TN Oral cavity 5.2 mm –
Clark et al. [21] 2006 105 Any TN Oral cavity 5 mm –
Wallwork et al. [22] 2007 53 Any TN FOM 7.5 mm –
Suzuki et al. [23] 2007 48 T1-2N0 FOM 5 mm –
Okura et al. [24] 2008 43 Any TN Tongue 9.7 mm –
Kim et al. [25] 2008 82 Any TN Oral cavity 8 mm 8 mm
El-Okeily et al. [26] 2008 124 T1-3N0 Oral cavity 6.5 mm 6.5 mm
Natori et al. [27] 2008 110 Any TN Tongue 8 mm 8 mm
Huang et al. [2] 2009 1,136 Any TN Oral cavity 4 mm –
99Patients underwent transoral excision (n=30), CO2 laser
excision (n=3)or photodynamictherapy (PDT) (n=29),ora
combination of surgery with postoperative radiotherapy (n=
3). Within the group of patients treated with PDT (n=29) the
localisations were as follows: 13 tumours of the tongue, 13
in the ﬂoor of the mouth and three elsewhere in the mouth.
Twelve patients underwent a primary neck dissection.
Histopathological data on thickness were available in
all 33 surgically treated patients.
Current treatment protocol
US measurement of tumour thickness is currently used to
select patients treatable with PDT. In tumours of less than
5-mm thick, PDT treatment can be used as light
penetration up to 1 cm. We chose PDT especially in cases
where surgery carried a risk of Warthin’s duct obstruction
or a marginal mandibulectomy. For thicker tumours, we
always perform a local excision. The neck is staged using
US-guided aspiration cytology (USgFNAC) and a sentinel
node procedure in the case of a negative USgFNAC and
treatment of the primary with transoral excision. For
negative sentinel nodes, a wait-and-see policy is the
standard. In the case of positive sentinel nodes or a
positive USgFNAC, a neck dissection is carried out.
Measurement of tumour thickness
For US measurement of tumour thickness, an intra-
operative transducer (Philips IU-22, L15-7; 7–15 MHz)
was used (n=44). Before June 2007, a small parts
transducer probe (5–7 MHz) was used in 21 patients.
Tumour thickness was measured by placing the probe
directly on the lesion. The same radiologist performed all
intra-oral measurements on the outpatient clinic, 1 or
2 weeks before surgery without anaesthesia.
Using an US probe or MRI, the thickness of the tumour is
measured and not the depth of inﬁltration from an imaginary
line at the level of the mucosal surface. So, in this study we
measured maximal tumour thickness also with histopatho-
logical sections, and not the depth of inﬁltration.
On histological sections, the tumour thickness was
measured using the ocular micrometer. MRI examinations
were performed at 3.0 T (Philips Achieva release 3.2.1,
Philips Medical Systems, Best, The Netherlands) using a
dedicated 16-channel SENSE neurovascular coil.
The following series were acquired: STIR TSE COR,
TR (repetition time), IR (inversion time), TE (echo time)
3,880/180/20 ms, ETL: 12, FOV 300/228/40 mm, matrix:
320/320, 2 nex, slice thickness 4 mm; STIR TSE TRA,
TR/IR/TE 4,228/180/20, ETL: 12, FOV: 180/200/80 mm,
matrix 300/312, 2 nex, SW 3.5 mm, T1 TSE TRA, TR/
TE: 780/10, ETL: 5, FOV 180/180/80, matrix 384/384, 2
nex, slice thickness: 3.5 mm; T1 3D Thrive [performed
after intravenous injection of 15 cc gadoterate meglumine
(Dotarem)], TR/TE: 5/2,22, ETL:90, TA: 10, FOV 230/
272/220, matrix 288/288, 2 nex, slice thickness: 0.8 mm;
T1 TSE COR (post contrast): TR/TE: 812/10, ETL: 6,
FOV: 180/150/96 mm, matrix: 320/320, 3 nex, slice
thickness 3.5 mm.
The US ﬁndings of the patients treated with PDT and
CO2 laser could not be correlated with histopathological
measurements, for obvious reasons. Figure 1 shows the
measurement of a tumour using the three techniques.
Statistical analysis
The correlation between tumour thickness as measured by
US, MRI and in the histopathological sections was
evaluated. Pearson’s product correlation analysis was
performed on all data in order to determine the overall
correlation between them. The correlation between tumour
thickness and the presence of lymph node metastases was
analysed using the chi-squared test.
Results
Tumour thickness
For all 65 patients, US measurement of the oral lesion was
obtained. For 11 cases, intra-oral measurement was not
optimal due to limited mouth opening (n= 2 )o rt h e
impossibility of depicting the lesion (n=9). There was
no difference between the old and the new transducer
probe (four versus seven cases). Tumour thickness ranged
from 1 mm to 35 mm, with an average of 8 mm.
MRI was performed on 36 patients. Tumour thickness
ranged from 1 mm to 24 mm, with an average of 5 mm.
On histopathology (n=33), tumour thickness ranged
from 1 mm to 35 mm with an average of 8 mm.
Correlation with histopathology
Correlation between US and histopathology could be made
in 31 cases. For two surgically treated patients, UScould not
be performed. Correlation between MRI and histopathology
could be made in 22 cases. Pearson’s product correlation
(Figs. 2, 3) between US and MRI imaging was signiﬁcantly
different. With a correlation product of R=0.87, US
correlated better with histopathology than MRI (R=0.54).
Comparing the old transducer used before 2007 and the new
intra-oral probe, the Pearson’s product was respectively 0.05
versus 0.93 (Fig. 4)
Neck node metastases
In total, 12 patients (N0=6, N1=4, N2=2) initially
underwent 12 neck dissections, six therapeutic and six
elective. Of these 12 neck dissections, nine were patho-
logical N+ (pN+). In total, 53 clinically N0 patients did
100not undergo a neck dissection initially. During follow-up,
seven patients in this wait-and-see group developed a neck
node metastasis. Of these seven patients, three also had
local recurrence. Thus, a total of 16 of the 65 (25%)
patients were pN+. Of these 16 patients, US could be
performed in 13 cases.
Correlation of tumour thickness and lymph node
involvement
In the patients with available histopathological measure-
ment, histopathologically measured tumour thickness
was used to correlate with lymph node metastasis. For
Fig. 1 Tumour thickness on histology, US and MRI. a Histological section showing a tumour of the tongue. Tumour thickness is 8 mm (A
indicates diameter). b US picture of the same tumour of the tongue. c Tumour thickness measured on MRI
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Fig. 2 Correlation between tumour thickness on histological section
and by US; n=32, Pearson’sp r o d u c tR=0.87
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Fig. 3 Correlation between tumour thickness on histological section
and by MRI; n=22, Pearson’sp r o d u c tR=0.54
101the 32 cases in which histopathology was not possible,
the US-measured thickness was used (only measured
with the new intra-oral transducer probe). Therefore in
total, correlation was possible in 56 patients (Fig. 5).
One metastasis (1/20=5%) was found in patients with a
histological tumour thickness of 3 mm or less. Four
patients had cervical metastasis with tumour thickness
between 4 and 7 mm (4/22=18%). When the tumour
thickness exceeded 7 mm, the cervical metastases rate
increased to 57% (8/14). The difference in metastasis
for 7-mm tumour thickness was signiﬁcant at p=0.001.
Table 2 shows sensitivity and speciﬁcity by cut-off
value.
Correlation of tumour thickness and lymph node
involvement by site
Within the group of tongue carcinomas (n=36), none of
the patients had cervical metastasis with histological
tumour thickness of 3 mm or less (Fig. 6). Three patients
had cervical metastasis with tumour thickness between 4
and 7 mm (3/18=17%). When the tumour thickness
exceeded 7 mm, the cervical metastasis rate increased to
44% (4/9). The difference in metastasis for 7-mm tumour
thickness is signiﬁcant with p=0.03.
Within the group of ﬂoor of mouth carcinomas (n=15),
none of the patients had cervical metastasis with histo-
logical tumour thickness of 7 mm or less. When the
tumour thickness exceeded 7 mm, the cervical metastasis
rate increased to 80% (4/5). The difference in metastasis
for 7-mm tumour thickness is signiﬁcant at p=0.001.
Local recurrence versus tumour thickness
Tumour thickness measured by histopathology was used for
correlation with local recurrences. In our series, 12 patients
(12/65=19%) had a local recurrence within the follow-up
period. In ﬁve cases, recurrences occurred at a thickness of
0–4 mm (5/20=25%), none in the 4–7-mm group, two in the
7–10-mm group (2/7=22%) and no local recurrence
occurred in the group with tumour thickness of >9 mm.
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Fig. 4 Correlation between tumour thickness on histological section
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Fig. 5 Relationship between tumour thickness and cervical metastases
(n=56). Tumour thickness measured by intra-oral US probe, if not
available measured by histopathology N=56. Green represents the
patientswithno neckmetastasiswithin the 2-yearfollow-up period;blue
represents the patients with positive neck nodes during the follow-up
period
102There was no signiﬁcant correlation between chance of local
recurrence and tumour thickness.
Discussion
Synopsis of key/new ﬁndings
Although this is a retrospective study, all measurements
were performed only once and by the same observer, and
histology was not available in all patients, this study
demonstrates that the measurement of tumour thickness
with the new generation of intra-oral US transducers
correlates well with histopathological thickness in oral
cavity cancer (R=0.93). Between 2004 and 2007, we used
a non-dedicated small-parts transducer for measurement
and this yielded inferior results (R=0.05). This clearly
shows that it is necessary to use a dedicated small-parts
transducer to obtain reliable measurements.
In our study, MRI correlated less well with histopathol-
ogy than US (R=0.54). Worldwide, MRI measurements
are regularly performed in patients with oral cancer. In our
series, 13 of the 36 patients had lesions that could not be
measured by MRI because of superﬁcial growth, and these
were treated with PDT. Therefore, histopathological
measurement could not be performed. We were able to
perform correlation in 26 cases; in those cases whereboth
MRI and histopathological measurements were available,
the correlation was only R=0.54.
In this study, the risk of metastasis in the neck with
tumour thickness of 6 mm or less was 12% (ﬁve out of
42), whereas when tumour thickness was 7 mm or more
this risk was 57% (eight out of 14). For tongue carcinoma,
the risk of metastasis in the neck with tumour thickness of
6 mm or less was 11% (three out of 27), whereas when
tumour thickness was 7 mm or more this risk was 44%
(four out of nine). For ﬂoor of mouth carcinoma, the risk
of metastasis in the neck with tumour thickness of 6 mm
or less was 0% (none out of ten), whereas when tumour
thickness was 7 mm or more this risk was 80% (four out
of ﬁve). From these data we conclude that within the
overall group 7-mm tumour thickness is the cut-off value
that optimally stratiﬁes patients at a low versus high risk
of development of neck node metastases (p=0.001).
However, as shown in Table 2,i ti sam a t t e ro f
compromise between the sensitivity and speciﬁcity of a
given cut-off value to make a choice for the optimal value.
With a cut-off point of 7 mm, the sensitivity in our study
was 88% and the speciﬁcity 57% (Table 2). By dividing
the group by site, the optimal cut-off value would be
7 mm for both groups, although this was determined
within small groups (n=36 vs n=15).
Comparisons with other studies
Our ﬁndings, using the dedicated intra-oral/intra-operative
probe conﬁrm those published by Iro and Nitsche [12].
Rasgon et al. [3] showed that the percentage of cervical
lymph node metastases in lesions less than 5-mm thick
was signiﬁcantly lower compared with those with lesions
with a thickness more than 5 mm. Also, Shintani et al.
[10], who studied 24 patients, found a strong correlation
between tumour thickness measured with US and histol-
ogy (Pearson’s product R=0.98). They found that tumours
thicker than 20 mm showed discordant results, possibly
caused by tissue constriction during ﬁxation with for-
malin. Lesions smaller than 10 mm showed a signiﬁcantly
better correlation.
Shintani et al. [10] also compared the accuracy of US and
MRI in assessing tumour thickness. They found that US and
MRI correlated well with histopathology. However, MRI
could not identify most of the tumours less than 5.0-mm
Table 2 Sensitivity, speciﬁcity and signiﬁcance level versus cut-off points for tumour thickness
Cut-off point Sensitivity Speciﬁcity p value
Total group (n=56)
≥3 mm/<3 mm 90% 26% 0.275
≥4 mm /<4 mm 95% 33% 0.016
≥5 mm/<5 mm 88% 39% 0.019
≥6 mm/<6 mm 90% 53% 0.001
≥7 mm/<7 mm 88% 57% 0.001
≥8 mm/<8 mm 87% 64% <0.001
Tongue carcinomas (n=36)
≥3 mm/<3 mm 100% 21% 0.374
≥4 mm /<4 mm 100% 26% 0.089
≥5 mm/<5 mm 89% 29% 0.153
≥6 mm/<6 mm 92% 42% 0.017
≥7 mm/<7 mm 89% 44% 0.029
≥8 mm/<8 mm 86% 43% 0.081
Floor of mouth carcinomas (n=15)
≥3 mm/<3 mm 100% 40% 0.099
≥4 mm /<4 mm 100% 50% 0.029
≥5 mm/<5 mm 100% 67% 0.004
≥6 mm/<6 mm 100% 80% 0.001
≥7 mm/<7 mm 100% 80% 0.001
≥8 mm/<8 mm 100% 100% <0.001
103thick. Preda et al. [11] showed a signiﬁcant direct correlation
between the measured histological and measured MRI
tumour thickness (correlation coefﬁcient=0.80, p<0.0001).
In the literature, discussion remains as to which cut-off
point is optimal [1–4, 10–30], and in the more recent
literature, cut-off points range between 3 and 8 mm [2, 13].
In a large clinical review by Pentenero et al. [4], tumour
thickness was shown to be an important parameter for
predicting nodal metastases and for survival. They showed
that in the literature the cut-off thickness predicting neck
metastasisandsurvivalvariedfrom 1.5 mm to10mm.Thus,
it remains difﬁcult to choose a reliable cut-off point for
elective neck treatment and/or adjuvant radiotherapy.
The indicationfor electiveneck treatment ismainlybased
ontheexpectedriskofoccultmetastases.Withrespecttothis
risk assessment, Spiro et al. [1] retrospectively analysed
tumour thickness in 92 patients treated with surgery for
tongue and ﬂoor of mouth carcinomas. They concluded that
for clinically N0 oral cancer, elective neck dissection was
indicated in patients with depth invasion of more than 2 mm
because in these tumours the risk of metastases reached
40%. Fukano et al. [13], on the other hand, showed that
tongue tumours exceeding 5 mm carried a risk of 65% for
neck metastases, whereas those inﬁltrating 5 mm or less had
ar i s ko fo n l y6 %( s i g n i ﬁcant difference, p=0.0003).
A meta-analysis by Huang et al. [2]s h o w e da n
association between tumour thickness and cervical lymph-
node involvement and they stated that the optimal cut-off
point for tumour thickness is 4 mm. For oral cavity tumours
thicker than 4 mm, prophylactic neck management should
generally be recommended according to this study.
At present, little is known about the correlation between
tumour thickness and local recurrences of oral cavity
carcinomas. In our study, there was no signiﬁcant difference
in local recurrences using the cut-off point for tumour
thickness of more or less than 7 mm. Yuen et al. [6]s h o w e d
in 2002 that tumour thickness is prognostic for both nodal
and local recurrence in oral carcinomas. With a tumour
thickness less than 3 mm, 0% had local recurrences and 8%
had nodal metastases; tumour thickness of more than 3 mm
and up to 9 mm had 44% subclinical nodal metastasis and
7% local recurrence; tumour thickness of more than 9 mm
had 53% subclinical nodal metastasis and 24% local
recurrence. In our series, not enough patients with tumour
thickness of 10 mm or more were included to compare these
results. Extracting the results from Spiro et al. [1], local
recurrence occurred in 5% of the group of tumours with
thickness<2mm(2/40),9%(3/35)withinthegroup3–8mm
thick and 25% (4/17) for the group with thickness >9 mm.
Local recurrence occurred signiﬁcantly more in the group
with tumour thickness of more than 8 mm, at p=0.035. Yet
more factors like perineural invasion, radical operation,
postoperative treatment and N-staging should also be
considered in relation to local recurrence [6].
Clinical applicability of the study
From this and other studies, it is clear that state-of-the-art
US has a high correlation with histopathological thickness
[10, 12]. US thus seems to be the optimal technique in
patients with no limited mouth opening or base of tongue
involvement. US measurement is more reliable than MRI
for the measurement of tumour thickness, especially in
superﬁcial lesions.
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Fig. 6 Relationship between tumour thickness and cervical metastases
divided by site. Tumour thickness measured by intra-oral US probe, if
not available measured by histopathology. Green represents the patients
with no neck metastasis within the 2-year follow-up period; blue
represents the patients with positive neck nodes during the follow-up
period. a The group with tongue carcinoma (n=36); b the group with
ﬂoor of mouth carcinoma (n=15)
104All currently available literature shows depth of
invasion or tumour thickness measurements of the primary
tumour, most often only in small groups. The identiﬁca-
tion of a cut-off with adequate utility for clinical decision-
making requires large studies and independent validation.
Conclusion
Tumour thickness is an important predictive marker for
lymph node metastases. As such, it can help in decision-
making with regard to management of the primary tumour
and neck. Based upon our ﬁndings, a wait-and-see policy is
only warranted in superﬁcial lesions with tumour thickness
less than 7 mm, but only if regular follow-up using US-
guided aspiration of the neck is ensured [31, 32].
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which
permits any noncommercial use, distribution, and reproduction in
any medium, provided the original author(s) and source are
credited.
References
1. Spiro RH, Huvos AG, Wong GY, Spiro
JD, Gnecco CA, Strong EW (1986)
Predictive value of tumor thickness in
squamous carcinomas conﬁned to the
tongue and ﬂoor of the mouth. Am J
Surg 152:345–350
2. Huang SH, Hwang D, Lockwood G,
Goldstein DP, O’Sullivan B (2009)
Predictive value of tumor thickness for
cervical lymph-node involvement in
squamous cell carcinoma of the oral
cavity. Cancer 115:1489–1497
3. Rasgon BM, Cruz RM, Hilsinger RL,
Sawicki JE (1988) Relation of lymph-
node metastasis to histopathologic
appearance in oral cavity and
oropharyngeal carcinoma: a case series
and literature review. Laryngoscope
99:1103–1110
4. Pentenero M, Gandolfo S, Carrozzo M
(2005) Importance of tumor thickness
and depth of invasion in nodal
involvement and prognosis of oral
squamous cell carcinoma: a review of
the literature. Head Neck 27:1080–1091
5. Brandwein-Gensler M, Teixeira MS,
Lewis CM et al (2005) Oral squamous
cell carcinoma: histologic risk
assessment, but not margin status, is
strongly predictive of local disease-free
and overall survival. Am J Surg Pathol
29:167–178
6. Po Wing Yuen A, Lam KY, Lam LK et
al (2002) Prognostic factors of clinically
stage I and II oral tongue carcinoma-A
comparative study of stage, thickness,
shape, growth pattern, invasive front
malignancy grading, Martinez-Gimeno
score, and pathologic features. Head
Neck 24:513–520
7. Roepman P, de Jager A, Groot
Koerkamp MJ, Kummer A, Slootweg
PJ, Holstege FC (2006) Maintenance of
head and neck tumor gene expression
proﬁles upon lymph node metastasis.
Cancer Res 66:11110–11114
8. Biel MA (2007) Photodynamic therapy
treatment of early oral and laryngeal
cancers. Photochem Photobiol 83:1063–
1068
9. Bier-Laning CM, Durazo-Arvizu R,
Muzaffar K et al (2009) Primary tumor
thickness as a risk factor for
contralateral cervical metastases in T1/
T2 oral tongue squamous cell
carcinoma. Laryngoscope 119:883–888
10. Shintani S, Yoshihama Y, Ueyama Y et
al (2001) The usefulness of intraoral
ultrasonography in the evaluation of
oral cancer. Int J Oral Maxillofac Surg
30:139–143
11. Preda L, Chiesa F, Calabrese L et al
(2006) Relationship between histologic
thickness of tongue carcinoma and
thickness estimated from preoperative
MRI. Eur Radiol 16:2242–2248
12. Iro H, Nitsche N (1989) Intra-oral
sonography in neoplasms of the mouth
and base of the tongue. HNO 37:329–
332
13. Fukano H, Matsuura H, Hasegawa Y,
Nakamura S (1997) Depth of invasion
as a predictive factor for cervical lymph
node metastasis in tongue carcinoma.
Head Neck 19:205–210
14. Mohit-Tabatabai MA, Sobel H, Rush
BF, Mashberg A (1986) Relation of
thickness of ﬂoor of mouth stage I and
II cancers to regional metastasis. Am J
Surg 152:351–353
15. Woolgar JA, Scott J (1995) Prediction
of cervical lymph node metastasis in
squamous cell carcinoma of the tongue/
ﬂoor of mouth. Head Neck 17(6):463–
472
16. Martínez-Gimeno C, Rodriguez E, Vila
CN, Varela CL (1995) Squamous cell
carcinoma of the oral cavity: a
clinicopathologic scoring system for
evaluating risk of cervical lymph node
metastasis. Laryngoscope 105:728–733
17. Byers RM, El Naggar A, Lee YY et al
(1998) Can we detect or predict the
presence of occult nodal metastases in
patients with squamous carcinoma of
the oral tongue? Head Neck 20:138–
144
18. Scheer M, Kubler A, Manawi NN,
Reuther T, Zöller JE (2005)
Endosonographic imaging of tumor
thickness in oral squamous cell cancer
and its effect on the incidence of lymph
node metastases. Mund Kiefer
Gesichtschir 9:282–289
19. Veness MJ, Morgan G, Sathiyaseelan Y,
Gebski V (2005) Anterior tongue cancer
and the incidence of cervical lymph
node metastases with increasing tumour
thickness: should elective treatment to
the neck be standard practice in all
patients? ANZ J Surg 75:101–105
20. Jing J, Li L, He W, Sun G (2006)
Prognostic predictors of squamous cell
carcinoma of the buccal mucosa with
negative surgical margins. J Oral
Maxillofac Surg 64:896–901
21. Clark JR, Naranjo N, Franklin JH, de
Almeida J, Gullane PJ (2006)
Prognostic variables in N0 oral
carcinoma. Otolaryngol Head Neck
Surg 135:748–753
22. Wallwork BD, Anderson S, Coman WB
(2007) Squamous cell carcinoma of the
ﬂoor of the mouth: tumour thickness
and the rate of cervical metastasis. ANZ
J Surg 77:761–764
23. Suzuki M, Suzuki T, Asai M et al
(2007) Clinicopathological factors
related to cervical lymph node
metastasis in a patient with carcinoma
of the oral ﬂoor. Acta Otolaryngol
Suppl 559:129–135
24. Okura M, Iida S, Aikawa T et al (2008)
Tumor thickness and paralingual
distance of coronal MR imaging
predicts cervical node metastases in oral
tongue carcinoma. AJNR Am J
Neuroradiol 29:45–50
25. Kim SY, Roh J, Kim JS et al (2008)
Utility of FDG PET in patients with
squamous cell carcinomas of the oral
cavity. Eur J Surg Oncol 34:208–215
10526. El-Okeily M, El-Bouihi M, Ricard AS
et al (2008) Mouth ﬂoor and mobile
tongue epidermoid carcinomas
thickness: prognostic value. Rev
Stomatol Chir Maxillofac 109:81–85
27. Natori T, Koga M, Anegawa E et al
(2008) Usefulness of intra-oral
ultrasonography to predict neck
metastasis in patients with tongue
carcinoma. Oral Dis 14:591–599
28. Jones KR, Lodge-Rigal R, Reddick RL
et al (1992) Prognostic factors in the
recurrence of stage I and II squamous
cell cancer of the oral cavity. Arch
Otolaryngol Head Neck Surg 118:483–
485
29. Hosal AS, Unal O, Ayhan A (1998)
Possible prognostic value of
histopathologic parameters in patients
with carcinoma of the oral tongue. Eur
Arch Otorhinolaryngol 255:216–219
30. Nathanson A, Agren K, Biorklund A et
al (1989) Evaluation of some prognostic
factors in small squamous cell
carcinoma of the mobile tongue: a
multicentre study in Sweden. Head
Neck 11:387–392
31. Van den Brekel MW, Stel HV,
Castelijns JA, Croll GJ, Snow GB
(1991) Lymph node staging in patients
with clinically negative neck
examinations by uﬂtrasound and
ultrasound-guided aspiration cytology.
Am J Surg 162:362–366
32. Van den Brekel MW (1996) US-guided
ﬁne-needle aspiration cytology of neck
nodes in patients with N0 disease.
Radiology 201:580–581
106